The $556 million settlement announced in January between the U.S. Department of Justice and Kaiser Permanente affiliates represents a turning point for Medicare Advantage oversight.
Federal prosecutors alleged that Kaiser submitted unsupported diagnosis codes to increase risk-adjusted payments, largely by adding diagnoses after patient encounters that neither drove care nor reflected active management. The settlement, which covers conduct spanning nearly a decade, follows similar enforcement actions involving other Medicare Advantage organizations and reinforces a consistent message from regulators. At the same time, this viral news item about fraud allegations and eye-popping financial settlements overlooks a less-discussed reality: such outcomes are highly avoidable.
That is because tools exist today for health systems – and government auditors – to identify unsupported diagnoses, validate documentation, and prevent overcoding. When applied effectively, these capabilities enable health systems to detect risks early, address issues before submission, and materially reduce exposure to regulatory action.
A systemic challenge
Enrollment in Medicare Advantage continues to grow and now includes more than half of all Medicare beneficiaries. With that growth comes increased federal spending and increased scrutiny. Multiple government reports and independent studies have concluded that Medicare Advantage plans receive substantially higher payments than traditional Medicare, driven in large part by higher coding intensity.
The Department of Justice complaint against Kaiser alleged practices that many clinicians and compliance leaders recognize as industry-wide risks. Physicians were queried to add diagnoses long after visits concluded. Historical problem lists were mined for conditions that lacked evidence of active care. Financial incentives were tied to achieving diagnosis targets rather than improving patient outcomes. These practices created exposure under the False Claims Act because the documentation failed to meet Centers for Medicare and Medicaid Services (CMS) requirements.
The scale of the Kaiser settlement reflects the scale of the underlying problem across healthcare. Similar allegations have appeared in recent investigations involving other national payers, including Cigna, which settled in 2023. The question now facing policymakers is how to detect similar activity consistently and efficiently.
Limitations of manual audits
Current Medicare Advantage audit approaches rely heavily on retrospective chart reviews of limited samples. These methods are slow, expensive, and inherently constrained by human capacity. Reviewing a small subset of records makes it difficult to identify systemic documentation patterns across millions of encounters.
As enrollment grows, the mismatch between audit scope and program scale widens. Manual review alone cannot provide the level of oversight required to protect taxpayers while maintaining confidence in the Medicare Advantage model. Simply expanding audit team size without changing the underlying approach will, in turn, increase costs without proportionally improving effectiveness.
Verifying documentation at scale
Clinically grounded documentation review tools, however, now exist that can analyze large volumes of medical records and evaluate whether claimed diagnoses are supported by diagnostically relevant findings. These tools examine encounter documentation for evidence of assessment, evaluation, and management that aligns with Medicare Advantage requirements.
Such clinically grounded systems do not replace clinicians or auditors. They enable targeted review by identifying records that warrant closer examination. In practical terms, thousands of charts can be screened in minutes to surface outliers where diagnoses lack supporting documentation. Human reviewers can then focus their expertise where risk is highest.
Importantly, these same capabilities can be used prospectively. Health systems and physician organizations can review documentation before submission to identify clinically meaningful gaps, correct errors, and reduce exposure. This approach supports compliance while reinforcing appropriate clinical documentation practices.
Moving from concept to practice
Automated and targeted audit capabilities serve multiple stakeholders. For example, regulators gain a scalable process for enforcing program rules, while health systems gain clarity on documentation expectations. On a smaller scale, clinicians gain feedback that aligns coding with actual care delivery while patients benefit from medical records that accurately reflect their health status, which matters in both routine and emergency care.
The Kaiser settlement demonstrates that enforcement risk is real and substantial, but it also highlights an opportunity. Medicare Advantage oversight does not require years of new rulemaking or experimental pilots because the technical capability to validate documentation at scale already exists and can be deployed today.
As Medicare Advantage continues to expand, maintaining public trust in the program depends on ensuring that payments reflect real patient needs and real clinical work. The path forward, which should start today, favors accuracy, transparency, and tools that support both compliance and care integrity.
Photo: SARINYAPINNGAM, Getty Images
David Lareau is Chief Executive Officer of Medicomp. Lareau joined Medicomp in 1995 and has responsibility for operations and product management, including customer relations and marketing. Prior to joining Medicomp, Lareau founded a company that installed management communication networks in large enterprises such as The World Bank, DuPont and Sinai Hospital in Baltimore. The Sinai Hospital project, one of the first PC-based LAN systems using email and groupware, was widely acknowledged as one of the largest and most successful implementations of this technology.
Lareau’s work at Sinai led to the founding of a medical billing company that led, in turn, to his partnership with Medicomp. Realizing that the healthcare industry made less use of information technology than almost any other industry, particularly in the area of clinical care, Lareau immediately saw the potential for Medicomp’s powerful technologies and joined the company to help fulfill Peter Goltra’s vision.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.
